Unicharm Co. (OTCMKTS:UNICY - Get Free Report) was the target of a large decline in short interest in the month of May. As of May 31st, there was short interest totalling 40,800 shares, a decline of 75.2% from the May 15th total of 164,200 shares. Approximately 0.0% of the shares of the company are sold short. Based on an average daily volume of 508,700 shares, the days-to-cover ratio is presently 0.1 days.
Unicharm Stock Performance
Shares of OTCMKTS UNICY traded up $0.08 during midday trading on Thursday, hitting $4.07. 274,290 shares of the company's stock traded hands, compared to its average volume of 521,829. The firm has a fifty day moving average of $4.26 and a 200 day moving average of $4.25. Unicharm has a 1 year low of $3.48 and a 1 year high of $8.10. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.79 and a current ratio of 2.22. The stock has a market capitalization of $11.93 billion, a price-to-earnings ratio of 20.35 and a beta of 0.28.
Unicharm (OTCMKTS:UNICY - Get Free Report) last announced its earnings results on Friday, May 9th. The company reported $0.05 EPS for the quarter. Unicharm had a net margin of 8.67% and a return on equity of 10.24%. The business had revenue of $1.49 billion during the quarter, compared to analysts' expectations of $1.69 billion. On average, analysts forecast that Unicharm will post 0.17 earnings per share for the current year.
About Unicharm
(
Get Free Report)
Unicharm Corporation engages in the manufacturing and sale of wellness, feminine, baby and children, kirei, and pet care products in Japan and internationally. The company's baby and child care products, including disposable diapers and wipes under the Moony, MamyPoko, Oyasumiman, and Torepanman brands; feminine care products comprise napkins, tampons, panty liners, sanitary short, panty liners, and other feminine care products under the Sofy, Center-In, and Unicharm brand names; and wellness care products include napkin-type incontinence pads, pants-type diapers, tape-type diapers, pants-type specialized urine pads, and tape-type specialized urine pads under the Lifree and Charmnap brand.
See Also
Before you consider Unicharm, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Unicharm wasn't on the list.
While Unicharm currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
